Cargando…
Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer
Posterior reversible encephalopathy syndrome (PRES) is a rare, reversible neurological disease that is frequently associated with the use of targeted therapy agents. In this case study, we examine the development of posterior reversible encephalopathy syndrome (PRES) in a 44-year-old woman with meta...
Autores principales: | Wang, Lu, Zeng, Zhaohao, Wu, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570160/ https://www.ncbi.nlm.nih.gov/pubmed/37581770 http://dx.doi.org/10.1007/s10072-023-06991-7 |
Ejemplares similares
-
Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer
por: Shu, Yefei, et al.
Publicado: (2021) -
Real-World Data: Fruquintinib in Treating Metastatic Colorectal
Cancer
por: Liu, Shuai, et al.
Publicado: (2022) -
The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer
por: Song, Yan, et al.
Publicado: (2021) -
Acute aortic dissection caused by fruquintinib for metastatic colorectal cancer—a case report and literature review
por: Deng, Ya-Ya, et al.
Publicado: (2023) -
Intracranial hypotension and PRES: case report
por: Pugliese, Silvia, et al.
Publicado: (2010)